Case File
efta-01358144DOJ Data Set 10OtherEFTA01358144
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01358144
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Arthur Tendler
Sent:
4/22/2014 9:05:52 AM
To:
CC:
Amanda Kirby
Katy Cheng
Marjorie Flash
Subject:
Regulation E Disclosure IC]
Attachments: Jeffrey Epstein Reg E Consent for 4.22.14 Wire.pdf; pic08146.gif; pic08924.gif
Classification: confidential
Please provide your e-mail consent to the disclosure (we will need your
approval before we release the wire)
Thanks for your help
(see attached file: Jeffrey Epstein Reg E consent for 4.22.14 wire.pdf)
Kind regards,
Arthur Tendler
(Embedded image moved to file: pic08146.gif)
Arthur Tendler
Vice President
Deutsche Bank Trust Company Americas
wealth Management Products
10005-2836
Important Information Regarding Trading Instructions:
Regarding mutual fund and Corporate Action transactions: Deutsche Bank Trust
Company Americas (the "Bank") shall only be obligated to act on any
instructions to buy or sell mutual funds or elect on a Corporate Action
instruction that you deliver via email, voicemail or facsimile, at such time
as your Bank representative has confirmed via email or telephone that the Bank
has received your request.
with respect to all other trading instructions (including, without limitation,
foreign currency transactions), The Bank shall only be obligated to act on any
such instructions at such time as your Bank representative has confirmed that
the Bank has received your request via telephonic communication.
Please note, automated electronic responses such as "read receipts" or fax
confirmations do not constitute confirmation by the Bank that your
instructions have been received. If you submit trade instructions and do not
receive a timely confirmation that the Bank has received such instructions,
please contact your Bank representative immediately.
This communication may contain confidential and/or privileged information. If
you are not the intended recipient (or have received this communication in
error), please notify the sender immediately and delete the communication from
your computer. Any unauthorized copying, disclosure or distribution of the
material is this communication is prohibited. Deutsche Bank does not render
legal or tax advice, and information contained in this communication should
not be regarded as such.
(Embedded image moved to file: pic08924.gif)
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e)
DB-SDNY-0045542
CONFIDENTIAL
SDNY_GM_00191726
EFTA01358144
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.